emjreviews.com11h
Lupus Vasculitis, A Rare Diagnosis and a Therapeutic Challenge: A Case Report
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...
First for Women on MSN22h
Selena Gomez's Lupus Journey: The Signs She Wishes She Hadn't Ignored
Selena Gomez has been in the spotlight thanks to her Golden Globe nomination for Emilia Pérez and her engagement to musician ...
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...
GlobalData on MSN1d
Royalty Pharma pays $250m for rights to Biogen’s lupus drug
Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus medication litifilimab. In return, Royalty Pharma will receive undisclosed ...
lupus.bmj2d
Long-term safety and efficacy of the combination of belimumab and rituximab in the treatment of severe and refractory SLE: a preliminary report
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.
lupus.bmj2d
Time trends of variability in disease activity in systemic lupus erythematosus
Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...
FierceBiotech2d
Biogen enlists Royalty for pursuit of lupus crown, securing $250M to fund phase 3 program
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...